Your browser is no longer supported. Please, upgrade your browser.
Novan, Inc.
Index- P/E- EPS (ttm)-2.69 Insider Own0.10% Shs Outstand15.00M Perf Week111.07%
Market Cap162.05M Forward P/E- EPS next Y-1.51 Insider Trans- Shs Float14.07M Perf Month52.19%
Income-32.10M PEG- EPS next Q-0.53 Inst Own11.70% Short Float2.18% Perf Quarter-3.07%
Sales4.50M P/S36.01 EPS this Y74.60% Inst Trans24.78% Short Ratio0.09 Perf Half Y192.63%
Book/sh0.06 P/B289.17 EPS next Y20.00% ROA-68.50% Target Price- Perf Year319.08%
Cash/sh3.50 P/C4.96 EPS next 5Y- ROE- 52W Range3.00 - 25.90 Perf YTD113.41%
Dividend- P/FCF- EPS past 5Y29.70% ROI-755.40% 52W High-40.35% Beta-0.06
Dividend %- Quick Ratio4.80 Sales past 5Y- Gross Margin- 52W Low415.00% ATR2.03
Employees23 Current Ratio4.80 Sales Q/Q-33.30% Oper. Margin- RSI (14)63.90 Volatility20.80% 12.40%
OptionableNo Debt/Eq1.00 EPS Q/Q64.20% Profit Margin- Rel Volume1.11 Prev Close17.35
ShortableYes LT Debt/Eq0.11 EarningsMay 11 AMC Payout- Avg Volume3.48M Price15.45
Recom2.00 SMA2048.18% SMA5030.61% SMA20055.18% Volume3,794,505 Change-10.95%
Apr-22-21Initiated ROTH Capital Buy $3
Jan-06-20Downgrade Piper Jaffray Overweight → Neutral
Jun-14-21 02:05PM  
Jun-11-21 02:33PM  
Jun-10-21 08:30AM  
Jun-07-21 08:30AM  
May-25-21 08:00AM  
May-24-21 06:54AM  
May-11-21 04:05PM  
May-03-21 08:30AM  
Apr-22-21 09:00AM  
Mar-08-21 04:06AM  
Mar-05-21 09:00AM  
Mar-02-21 08:30AM  
Feb-25-21 07:30AM  
Feb-01-21 08:05AM  
Jan-29-21 04:05PM  
Jan-21-21 05:12AM  
Jan-19-21 09:00AM  
Jan-13-21 02:24PM  
Jan-08-21 09:00AM  
Dec-21-20 09:00AM  
Dec-15-20 09:00AM  
Dec-14-20 10:34AM  
Dec-03-20 04:12AM  
Nov-10-20 05:12AM  
Nov-04-20 07:30AM  
Oct-30-20 07:30AM  
Oct-21-20 09:00AM  
Oct-14-20 11:40AM  
Sep-24-20 07:05AM  
Sep-22-20 08:30AM  
Sep-14-20 09:05AM  
Sep-09-20 08:05AM  
Sep-04-20 10:17AM  
Sep-03-20 09:05AM  
Aug-31-20 08:05AM  
Aug-25-20 07:21AM  
Jul-30-20 06:50AM  
Jul-28-20 08:05AM  
Jul-23-20 08:05AM  
Jun-29-20 08:35AM  
Jun-26-20 08:21AM  
Jun-25-20 08:00AM  
Jun-24-20 08:15AM  
Jun-23-20 08:49AM  
Jun-17-20 05:30AM  
May-01-20 07:54AM  
Apr-30-20 04:05PM  
Apr-21-20 08:19AM  
Apr-20-20 04:05PM  
Apr-06-20 09:42AM  
Apr-03-20 08:15AM  
Apr-02-20 02:54PM  
Mar-31-20 10:51AM  
Mar-30-20 10:36AM  
Mar-26-20 04:05PM  
Mar-24-20 08:10AM  
Mar-23-20 08:15AM  
Mar-13-20 07:12AM  
Mar-11-20 09:54AM  
Mar-06-20 10:56AM  
Mar-03-20 04:05PM  
Feb-28-20 03:09PM  
Feb-27-20 11:20PM  
Feb-26-20 02:57PM  
Feb-24-20 02:59PM  
Feb-20-20 08:15AM  
Feb-06-20 08:30AM  
Jan-29-20 03:40AM  
Jan-06-20 10:06AM  
Jan-03-20 02:28PM  
Jan-02-20 04:15PM  
Dec-18-19 02:50PM  
Dec-06-19 12:29PM  
Nov-30-19 09:38AM  
Nov-19-19 06:19AM  
Oct-28-19 10:32AM  
Oct-22-19 09:54AM  
Oct-18-19 08:30AM  
Oct-08-19 08:30AM  
Sep-20-19 08:30AM  
Sep-11-19 04:05PM  
Sep-05-19 01:25PM  
Sep-03-19 04:05PM  
Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STAFFORD PAULA BPresident and CEOMar 26Buy1.4370,000100,100150,693Mar 29 04:07 PM